425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
- Filed
- Accession number
- 0001213900-26-111424
Documents
- CURRENT REPORT 425
- AMENDMENT NO. 1 TO THE AMENDED AND RESTATED DEFINITIVE MERGER AGREEMENT, DATED OCTOBER 13, 2026, BETWEEN DRUGS MADE IN AMERICA ACQUISITION CORP. AND POWER ANALYTICS GLOBAL CORP EX-2.1